Expression of the Neomycin-Resistance (neo) Gene Induces Alterations in Gene Expression and Metabolism

Alfons Valera, Jose Carlos Perales, Maria Hatzoglou, Fatima Bosch

Research output: Contribution to journalArticleResearchpeer-review

93 Citations (Scopus)


The amino 3′-glycosyl phosphotransferase (neo) gene is the selectable marker most widely used in stable transfection or infection protocols. Because the neo gene product has phosphotransferase activity, it might modify the phosphorylation state when introduced in mammalian cells. NIH-3T3 fibroblast cells expressing the neo gene, after either infection with retroviral vectors or transfection with plasmids, showed a 50% reduction in both fructose 2,6-bisphosphate (Fru 2,6-P2) concentration and lactate production compared with control NIH-3T3 cells, indicating that these neo-expressing cells are less glycolytic. In addition, a marked decrease in the levels of mRNA for the procollagen 1α and fibronectin genes was also observed in neo-expressing NIH-3T3 cells. This decrease was concomitant with an increase in the mRNA concentration of the endogenous c-myc gene. FTO-2B rat hepatoma cells also showed modifications in gene expression when the neo gene was introduced by stable transfection or infection. In these cells an increase in both P-enolpyruvate carboxykinase (PEPCK) and tyrosine aminotransferase (TAT) mRNA was observed. These results suggest that neo gene expression may induce changes in the cells, which should be considered when neo-selected cells are used to deliver specific genes in different therapy approaches and in embryo manipulation. © 1994, Mary Ann Liebert, Inc. All rights reserved.
Original languageEnglish
Pages (from-to)449-456
JournalHuman Gene Therapy
Issue number4
Publication statusPublished - 1 Apr 1994


Dive into the research topics of 'Expression of the Neomycin-Resistance (neo) Gene Induces Alterations in Gene Expression and Metabolism'. Together they form a unique fingerprint.

Cite this